Tissue fusion method using collagenase for repair of soft tissue

Abstract

The present invention provides a method of using locally administered collagenase as a non-invasive means of enhancing cell release from the cartilage or fibrocartilage tissues adjacent to a disease or injury site. The subsequent migration of cells from these tissues into the lesion or wound, followed by deposition of the appropriate extracellular matrix, results in closure of the lesion or fusion of a tissue gap.

Description

FIELD OF THE INVENTION[0001]The field of art to which this invention relates is compositions for use in methods of treating and repairing soft tissue, more particularly collagenase compositions and methods of using such compositions for tissue fusion to treat or repair soft tissue.BACKGROUND OF THE INVENTION[0002]Tissue healing is a complex process involving cells, matrix components and biological factors. Whether the damage to the tissue is caused by injury or disease, a key component of tissue healing is the migration of native cells from surrounding tissue into the wound or lesion, where they can participate in the healing process, whether by interaction with each other, expression of the appropriate biological factors or by the deposition of new extracellular matrix (ECM). In most tissues, this is accomplished by immediate massive matrix degradation via a post-injury response. In the case of vascularized tissue, matrix metalloproteinases (MMPs), e.g., collagenases, are released ...

AI Technical Summary

Benefits of technology

The present invention provides a method for promoting healing of injuries to cartilaginous tissue by using collagenases, which are natural enzymes that target extracellular matrix collagens. This method can be used in various surgical procedures and does not affect cell body itself, thus minimizing cell death. The use of this method improves the outcome of tissue repair surgical procedures and promotes the natural healing process.

Problems solved by technology

Consequently, such tissues often do not heal to any significant degree after an acute injury or long term tissue degeneration.

In the case of cartilage lesions, because of the inefficient matrix degradation, fibrous tissue sometimes fills the defect gap.

However, such fibrous tissue is not mechanically suitable as a replacement for the native tissue.

While the transplanted tissue often integrates with the native subchondral bone, the method often suffers from poor integration at the peripheral interface between native and transplanted cartilage.

Although this method does produce the effect of tissue filling, the new tissue is not true cartilage and therefore cannot withstand long term articular loading.

However, the long-term clinical benefit of the method still needs to be established.

The primary shortcoming of this technology is that the procedure produces substantial heat, often resulting in death of local cells that are the vital source for rebuilding the tissue.

A suitable balance between thermally driven tissue welding and cell viability is apparently difficult to achieve.

Surgical resection is currently the standard of care for such injuries, which often results in long-term degeneration of the underlying articular cartilage.

Similar difficulties are encountered in the repair of the so-called triangular fibrocartilage complex (TFCC), a meniscus-like structure at the base of the wrist, as well as in the repair of ligament, tendon and intervertebral disc injuries.